A federal website notice, deleted and then reposted by the administration, provides a hint that more aggressive pricing policies may be coming. By Margot Sanger-Katz and Rebecca Robbins The Trump ...

One of the most contentious issues in the debate over the Trans-Pacific Partnership concerns the agreement’s implications for drug prices in developing countries. Will the TPP’s intellectual property ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ...

President Donald Trump on Tuesday announced that pharmaceutical giant Pfizer would sell its drugs to a government program at discounted rates, acceding to his long-running push to lower U.S. drug ...

How Democrats plan to pivot to midterms, a White House deal lowers prices of weight-loss drugs, and more Length: Long Speed: 1.0x President Trump announced on Nov. 6 that the manufacturers of popular ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.

We have seen enough Donald Trump–branded consumer pitches—Trump Steaks, Trump Vodka, Trump Airlines, Trump Watches—to know that the quality of the service is less important than giving the impression ...

President Donald Trump announced a deal with the major pharmaceutical company, Pfizer, on Tuesday to bring down the costs of its products in line with the lowest price paid by other developed nations.

Today in health care, aside from the overarching debate about keeping people insured, nothing likely dominates the debates, especially the political ones, more than the cost of prescription drugs.

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription drugs, including popular weight-loss medications Ozempic and Wegovy, asthma ...